Getting high in senior year: NYU study examines reasons for smoking pot

Key points
- Approximately 70% of the 2.8 million individuals who initiated use of illicit drugs in 2013 reported that marijuana was their first drug.
- Monitoring the Future data were collected through a research grant (R01 DA-01411) from the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH).
- CDUHR is a Core Center of Excellence funded by the National Institute on Drug Abuse (Grant #P30 DA011041).
- NYU Langone Medical Center, a world-class, patient-centered, integrated academic medical center, is one of the nation's premier centers for excellence in clinical care, biomedical research, and medical education.
Marijuana is the most prevalent drug in the U.S. Approximately 70% of the 2.8 million individuals who initiated use of illicit drugs in 2013 reported that marijuana was their first drug. Despite extensive research examining potential links between marijuana use and other drug use, the literature is currently lacking data regarding which illicit marijuana users are most likely to engage in use of other illicit drugs.
A new study, published in the American Journal of Drug and Alcohol Abuse by researchers affiliated with New York University's Center for Drug Use and HIV Research (CDUHR), examines how reasons for illicit marijuana use relates to the use of other drugs individually, rather than grouping them into a single "illicit drug" group.
"Aside from marijuana, a wide range of illicit drugs are prevalent, each having different use patterns, and different effects and dangers associated with use," said Joseph J. Palamar, PhD, MPH, a CDUHR affiliated researcher and an assistant professor of Population Health at NYU Langone Medical Center (NYULMC). "Our research helped to identify subtypes of illicit marijuana users who use other drugs, as this may be able to inform prevention efforts."
The cross-sectional study, "Reasons for Recent Marijuana Use in Relation to Use of Other Illicit Drugs among High School Seniors in the United States," draws data from Monitoring the Future (MTF), a nationwide ongoing annual study of the behaviors, attitudes, and values of American secondary school students. The MTF survey is administered in approximately 130 public and private schools throughout 48 states in the US. Roughly 15,000 high school seniors are assessed annually.
Analyses focused on data collected from high school seniors (12th graders), in 12 cohorts (2000-2011; weighted N=6,481), who reported use of marijuana in the last 12 months. The analysis examined self-reported use of eight other illicit drugs: powder cocaine, crack, heroin, LSD, other psychedelics, and nonmedical use of amphetamine/stimulants, tranquilizers/benzodiazepines, and narcotics (other than heroin).
The researchers found that using marijuana to alleviate boredom was associated with increased risk for reporting use of powder cocaine or hallucinogens other than LSD. Nearly a fifth (19.8%) of the sample reported using marijuana for insight or understanding and this reason was also positively related to use of hallucinogens other than LSD. And, 11% reported using marijuana to increase the effects of other drugs; this was a consistent correlate of reporting use of each drug examined in this analysis, even when controlling for sociodemographic and substance use variables.
"Interestingly, we found that using marijuana 'to experiment' decreased risk of reporting use of each of the eight drugs examined before adjusting for other variables," said Palamar. "The marijuana users in this sample who used to experiment were consistently at low risk for use of nonmedical use of prescription narcotics."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsFDA issues warning for high doses of Zocor
Patients on the highest approved dose of the cholesterol-lowering drug Zocor may be at increased risk of muscle injury, U.S. regulators warned on Friday. Made by Merck & Co and sold under the brand name Zocor,…
20 March 2010
NewsYears of smoking associated with lower Parkinson's risk, not number of cigarettes per day
Researchers have new insight into the relationship between Parkinson's disease and smoking. Several studies have shown that smokers have a lower risk of developing Parkinson's disease. A new study published in the March…
12 March 2010
NewsNicotine levels higher in children exposed to secondhand smoke in the home
New research published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, supports the World Health Initiative's efforts for a home smoking ban, according to…

